Full name
NOWA PANACEA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA JAWNA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,3 | 0,4 | 0,3 | -24 |
Gross profit (loss) | 0,3 | 0,5 | 0,5 | -9,1 |
EBITDA | 0,3 | 0,4 | 0,3 | -23,5 |
Short time liabilities | 1,2 | 1,3 | 1,4 | 9,1 |
Other operating costs | 0 | 0 | 0 | -3,3 |
Equity capital | 0,6 | 1,1 | 1,6 | 41,3 |
Operating profit (EBIT) | 0,3 | 0,4 | 0,3 | -24,8 |
Assets | 1,9 | 2,5 | 3,1 | 23,7 |
Net profit (loss) | 0,3 | 0,5 | 0,5 | -9,1 |
Cash | 0 | 0 | 0 | -91,4 |
Net income from sale | 6,2 | 7,4 | 8,2 | 10,3 |
Liabilities and provisions for liabilities | 1,2 | 1,3 | 1,5 | 8,9 |
Working assets | 1,8 | 2,4 | 3 | 23,1 |
Other income costs | 0 | 0 | 0 | 15,7 |
Depreciation | 0 | 0 | 0 | 55,5 |
% | % | % | p.p. | |
Profitability of capital | 48 | 45,4 | 29,2 | -16,2 |
Equity capital to total assets | 33,3 | 45,8 | 52,3 | 6,5 |
Gross profit margin | 4,8 | 6,9 | 5,7 | -1,2 |
EBITDA Margin | 4,7 | 5,7 | 4 | -1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 72 | 64 | 63 | -1 |
Current financial liquidity indicator | 1.5146870613098145 | 1.87083101272583 | 2.1106226444244385 | 0,2 |
Net dept to EBITDA | -0.02333233132958412 | -0.03855997696518898 | -0.00431981822475791 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane